Tacrolimus Capsule
NDC Package 65897-0010-2
Package Information
Tacrolimus capsules is tacrolimus is used with other medications to prevent rejection of a kidney, heart, or liver transplant. This formulation utilizes a capsule delivery system. Marketed by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, this product is identified by NDC 65897-0010 and is authorized under FDA application ANDA210929.
Identification & Billing
- RxCUI: 198377 - tacrolimus 1 MG Oral Capsule
- RxCUI: 198377 - tacrolimus 1 MG (as anhydrous tacrolimus) Oral Capsule
- RxCUI: 313190 - tacrolimus 0.5 MG Oral Capsule
- RxCUI: 313190 - tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65897 - Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
- 65897-0010 - Tacrolimus
- 65897-0010-2 - 1 BAG in 1 CARTON / 10 BLISTER PACK in 1 BAG / 10 CAPSULE in 1 BLISTER PACK
- 65897-0010 - Tacrolimus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65897-0010-2 identifies a specific commercial package of 1 bag in 1 carton / 10 blister pack in 1 bag / 10 capsule in 1 blister pack of Tacrolimus, a human prescription drug labeled by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. This capsule is formulated for oral use and contains tacrolimus anhydrous as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd on July 11, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Tacrolimus is used with other medications to prevent rejection of a kidney, heart, or liver transplant. This medication belongs to a class of drugs known as immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own.
How is this Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65897001002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.